• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-09-20

  Saito and colleagues developed a direct three-dimensional cluster-culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte CYP enzyme and transporter activities, creating a more human-relevant platform for oral drug pharmacokinetic studies.

• Z-DEVD-FMK: Reading Cell-Death Signals

  2026-09-19

  Z-DEVD-FMK is a cell-permeable caspase-3 inhibitor for dissecting apoptosis, calpain inhibition, and neuroprotection. This guide distinguishes DEVD-sensitive apoptosis from caspase-1-driven pyroptosis and translates that distinction into better assay design.

• tFUS, SHP2, and NLRP3 Neuroinflammation After Stroke

  2026-09-18

  This study identifies the Nespas/miR-383-3p/SHP2 axis as a mechanistic link between low-intensity transcranial focused ultrasound stimulation and reduced NLRP3-mediated neuroinflammation after ischemic stroke. Using rat MCAO and BV2 oxygen-glucose deprivation/reperfusion models, the authors connect improved neurological outcomes with microglial pathway regulation, while also defining important limits for pharmacological translation.

• NSC 87877: A Causal Map for SHP2 Research

  2026-09-18

  NSC 87877 is a potent Shp2 inhibitor for testing how SHP2 activity connects receptor signaling with neuroinflammation. This article translates ischemic-stroke evidence into a causal assay framework while clarifying selectivity, controls, and interpretation limits.

• Isorhamnetin and PI3K/Akt-Driven Oocyte Maturation

  2026-09-17

  The reference study shows that Isorhamnetin improves porcine oocyte maturation in vitro, with 10 μM associated with increased polar body extrusion and reduced oxidative, mitochondrial, apoptotic, and endoplasmic reticulum stress. Its main innovation is to connect these protective effects with activation of the PI3K/Akt signaling pathway, providing a mechanistic framework for studying oocyte quality rather than treating the compound only as a general antioxidant.

• Dabigatran etexilate Research Workflows

  2026-09-17

  Build more interpretable thrombin and plasma-clotting assays with a concentration-controlled workflow for Dabigatran etexilate. This guide connects direct thrombin inhibition to anticoagulant for atrial fibrillation research while emphasizing stock preparation, matrix effects, controls, and troubleshooting.

• Taltirelin Acetate: Mechanism and Research Use

  2026-09-16

  Taltirelin acetate is an acetate salt of Taltirelin, an orally active, long-acting TRH analog used in neurobiology and formulation research. Evidence links Taltirelin to TRHR-MAPK-RARα-DRD2 signaling, striatal TH expression, motor improvement in rodent Parkinson’s disease models, and dopamine-related neuroprotection.

• Firefly Luciferase mRNA as a Delivery Calibrator

  2026-09-16

  Firefly Luciferase mRNA can serve as more than a luminescent endpoint: it is a systems-level calibrator for translation, delivery, stability, and assay quality. This article connects ARCA capping and 5-methoxyuridine chemistry with practical decisions informed by nanoparticle and lyophilization research.

• DNP-Induced seRNA Drives NPC Metastasis

  2026-09-15

  The 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as a regulator of nasopharyngeal carcinoma metastasis. Its integrated genomic and functional experiments connect seRNA-NPCm to an NPM1/c-Myc/NDRG1 regulatory axis, providing a mechanistic framework for studying how chemical exposure reshapes enhancer activity and metastatic behavior.

• DOM, 5-HT Receptors, and Biphasic Behavior

  2026-09-15

  This 2024 study shows that the inverted U-shaped behavioral responses to DOM in mice arise from distinct receptor mechanisms rather than a single 5-HT2A-driven process. Its pharmacological dissection separates 5-HT2A-dependent head twitching from 5-HT2C- and 5-HT1A-sensitive locomotor effects, while PTX experiments implicate Gαi/o signaling in the divergence between behavioral endpoints.

• RITA: Reading p53 Responses Beyond Viability

  2026-09-14

  RITA (NSC 652287) offers translational researchers a way to interrogate p53 activation, DNA cross-link biology, growth inhibition, and tumor response in a unified experimental framework. This thought-leadership guide explains how to move beyond headline potency values toward more decision-ready cancer biology, apoptosis assay, renal carcinoma research, and tumor xenograft model workflows.

• Mupirocin and Novobiocin Activity in Canine Staphylococci

  2026-09-14

  This study compared mupirocin and novobiocin susceptibility in meticillin-resistant and meticillin-susceptible staphylococci recovered from healthy dogs and dogs with superficial pyoderma. Its main contribution is a clinically relevant resistance-stratified dataset showing broadly preserved mupirocin activity, but more variable novobiocin activity among resistant isolates.

• ddATP as a Causal Probe of DNA Replication

  2026-09-13

  ddATP is more than a chain-terminating nucleotide: it can serve as a mechanistic perturbation for distinguishing DNA synthesis from DNA damage signaling. This article interprets evidence from mouse-oocyte break-induced replication and translates it into better assay design for sequencing, polymerase, and replication studies.

• WIP1, p38 MAPK, and Pyroptosis in Septic AKI

  2026-09-12

  The reference study identifies WIP1/PPM1D as a regulator that restrains p38 MAPK-linked pyroptosis in sepsis-associated acute kidney injury. By combining human tissue observations, mouse LPS injury, HK2-cell experiments, and single-cell sequencing, it provides a mechanistic framework for studying how PPM1D inhibition alters renal inflammation and tubular cell survival.

• Selective Autophagy Tunes IRF3 and Type I Interferon

  2026-09-11

  Wu et al. identify a virus load-dependent pathway in which CALCOCO2/NDP52-mediated selective autophagy removes IRF3, while PSMD14/POH1 preserves basal IRF3 through deubiquitination. The work explains how IRF3 stability is adjusted to sustain antiviral interferon production without allowing prolonged immune activation.

553 records 4/37 page Previous Next 12345 下5页 Last page